Sexual dysfunction in women with rheumatic diseases

Objective: to assess sexual function in female patients with rheumatoid arthritis (RA) and fibromyalgia (FM) and to identify the main risk factors of sexual dysfunction (SD).Patients and methods. 60 patients with FM (mean age 44.2±10.1 years) – Group 1; 69 patients with RA (mean age 45.0±9.6 years)...

Full description

Bibliographic Details
Main Authors: O. V. Teplyakova, A. A. Morozova, A. A. Popov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2021-06-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/1147
id doaj-23c73acbc21a41c3b23eccd5dbd05d2d
record_format Article
spelling doaj-23c73acbc21a41c3b23eccd5dbd05d2d2021-07-29T09:00:15ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2021-06-01153434910.14412/1996-7012-2021-3-43-492361Sexual dysfunction in women with rheumatic diseasesO. V. Teplyakova0A. A. Morozova1A. A. Popov2Ural State Medical University of the Ministry of Health of the Russian FederationUral State Medical University of the Ministry of Health of the Russian FederationUral State Medical University of the Ministry of Health of the Russian FederationObjective: to assess sexual function in female patients with rheumatoid arthritis (RA) and fibromyalgia (FM) and to identify the main risk factors of sexual dysfunction (SD).Patients and methods. 60 patients with FM (mean age 44.2±10.1 years) – Group 1; 69 patients with RA (mean age 45.0±9.6 years) – Group 2; and 100 healthy women controls (mean age 45.1±11.8 years) – Group 3 were enrolled in the study. Medical history, severity of pain at rest and during movement by visual analog scale (VAS), and anxiety and depression symptoms by hospital anxiety and depression scale (HADS) were assessed. Sexual function was evaluated by «Female Sexual Function index (FSFI)».Results and discussion. The overall sexual function score in Group 1 (12.7±9.0) was almost twice lower than in the control group (23.55±8.24, p<0.001) and in Group 2 (20.9±11, p<0.001). There was no difference between RA patients group and control group, where the average score for each of the scales was above 3 (with the exception of the «desire» scale). In FM patients all scales were below 3 points, which indicated significant SD, score on the «orgasm» scale was the lowest (1.8±0.9), and score on «absence of sexual pain» scale was the highest (2.6±1.8). SD in patients with FM was significantly driven by affective disorders presenting with anxiety and depression. Inflammatory activity and severity of pain by VAS were strongly associated with SD in RA group. The divorced person status was associated with the development of SD, regardless of nosological diagnosis.Conclusion. RA and FM have a negative impact on women's sexual function. The inflammatory disease activity is the main driver of SD in RA patients while affective disorders promote SD in FM patients.https://mrj.ima-press.net/mrj/article/view/1147sexual dysfunctionfibromyalgiarheumatoid arthritissexual function indexanxietydepression
collection DOAJ
language Russian
format Article
sources DOAJ
author O. V. Teplyakova
A. A. Morozova
A. A. Popov
spellingShingle O. V. Teplyakova
A. A. Morozova
A. A. Popov
Sexual dysfunction in women with rheumatic diseases
Современная ревматология
sexual dysfunction
fibromyalgia
rheumatoid arthritis
sexual function index
anxiety
depression
author_facet O. V. Teplyakova
A. A. Morozova
A. A. Popov
author_sort O. V. Teplyakova
title Sexual dysfunction in women with rheumatic diseases
title_short Sexual dysfunction in women with rheumatic diseases
title_full Sexual dysfunction in women with rheumatic diseases
title_fullStr Sexual dysfunction in women with rheumatic diseases
title_full_unstemmed Sexual dysfunction in women with rheumatic diseases
title_sort sexual dysfunction in women with rheumatic diseases
publisher IMA-PRESS LLC
series Современная ревматология
issn 1996-7012
2310-158X
publishDate 2021-06-01
description Objective: to assess sexual function in female patients with rheumatoid arthritis (RA) and fibromyalgia (FM) and to identify the main risk factors of sexual dysfunction (SD).Patients and methods. 60 patients with FM (mean age 44.2±10.1 years) – Group 1; 69 patients with RA (mean age 45.0±9.6 years) – Group 2; and 100 healthy women controls (mean age 45.1±11.8 years) – Group 3 were enrolled in the study. Medical history, severity of pain at rest and during movement by visual analog scale (VAS), and anxiety and depression symptoms by hospital anxiety and depression scale (HADS) were assessed. Sexual function was evaluated by «Female Sexual Function index (FSFI)».Results and discussion. The overall sexual function score in Group 1 (12.7±9.0) was almost twice lower than in the control group (23.55±8.24, p<0.001) and in Group 2 (20.9±11, p<0.001). There was no difference between RA patients group and control group, where the average score for each of the scales was above 3 (with the exception of the «desire» scale). In FM patients all scales were below 3 points, which indicated significant SD, score on the «orgasm» scale was the lowest (1.8±0.9), and score on «absence of sexual pain» scale was the highest (2.6±1.8). SD in patients with FM was significantly driven by affective disorders presenting with anxiety and depression. Inflammatory activity and severity of pain by VAS were strongly associated with SD in RA group. The divorced person status was associated with the development of SD, regardless of nosological diagnosis.Conclusion. RA and FM have a negative impact on women's sexual function. The inflammatory disease activity is the main driver of SD in RA patients while affective disorders promote SD in FM patients.
topic sexual dysfunction
fibromyalgia
rheumatoid arthritis
sexual function index
anxiety
depression
url https://mrj.ima-press.net/mrj/article/view/1147
work_keys_str_mv AT ovteplyakova sexualdysfunctioninwomenwithrheumaticdiseases
AT aamorozova sexualdysfunctioninwomenwithrheumaticdiseases
AT aapopov sexualdysfunctioninwomenwithrheumaticdiseases
_version_ 1721250133658566656